Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$28.96 USD
-1.04 (-3.47%)
Updated May 10, 2024 03:59 PM ET
After-Market: $28.95 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 13% (32 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.42 | 9.99 |
Current Quarter Estimate | 0.38 | 1.25 | 57.00 |
Year Ago Quarter Estimate | -0.02 | -4.28 | 52.54 |
Next Quarter Estimate | 0.39 | 1.37 | 61.00 |
Next Year Estimate | 1.95 | 7.08 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 8,100.00 | 19.30 | 15.67 |
Next Year | 18.90 | 13.60 | 9.31 |
Last 5 Years | -61.60 | 0.10 | 8.10 |
Next 5 Years | NA | 8.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 1.64 |
Price/Book (MRQ) | 1.71 | 1.15 |
Price/Cash Flow (MRFY) | 18.27 | 10.71 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -2.60% | -125.65% |
Return on Equity (TTM) | -1.68% | -2,370.91% |
Debt to Equity (MRQ) | 0.00 | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.